I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Discovery of the Potent and Highly Selective PARP7 Inhibito..:
Hongfeng Gu (14307312)
;
Wenxin Yan (6836804)
;
Yong Wang (12837)
...
https://figshare.com/articles/dataset/Discovery_of_the_Potent_and_Highly_Selective_PARP7_Inhibitor_as_a_Novel_Immunotherapeutic_Agent_for_Tumors/21787041. , 2022
Link:
https://doi.org/10.1021/acs.jmedchem.2c01452.s002
RT Journal T1
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
UL https://suche.suub.uni-bremen.de/peid=base-ftunivfreestate:oai:figshare.com:article_21787041&Exemplar=1&LAN=DE A1 Hongfeng Gu (14307312) A1 Wenxin Yan (6836804) A1 Yong Wang (12837) A1 Wenbo Xu (148718) A1 Lei Huang (35191) A1 Jieping Yang (660974) A1 Bingxin Zhai (14307315) A1 Hong Wang (13528) A1 Yupei Su (14307318) A1 Qihua Zhu (1555147) A1 Beibei Liu (833783) A1 Haiping Hao (23677) A1 Yi Zou (439002) A1 Yungen Xu (1434802) YR 2022 K1 Biochemistry K1 Cell Biology K1 Genetics K1 Pharmacology K1 Immunology K1 Cancer K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 Information Systems not elsewhere classified K1 novel immunotherapeutic agent K1 exhibits significantly stronger K1 excellent pharmacokinetic properties K1 tumor immunotherapeutic agent K1 innate immune response K1 high inhibitory potency K1 30 %) without K1 2397 </ b K1 50 </ sub K1 novel parp7 inhibitor K1 1 </ b K1 vivo </ K1 tumor microenvironment K1 irreversible inhibitor K1 immune activator K1 antitumor potency K1 67 %) K1 wide range K1 typically found K1 tumors parp7 K1 ribose polymerase K1 potential advantages K1 polyadenosine diphosphate K1 parp7 inhibition K1 negative regulator K1 mainly acts K1 low toxicity K1 findings reveal K1 cytochrome p450 K1 6 nm JF https://figshare.com/articles/dataset/Discovery_of_the_Potent_and_Highly_Selective_PARP7_Inhibitor_as_a_Novel_Immunotherapeutic_Agent_for_Tumors/21787041 LK http://dx.doi.org/https://doi.org/10.1021/acs.jmedchem.2c01452.s002 DO https://doi.org/10.1021/acs.jmedchem.2c01452.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)